In Wake of Smith & Nephew Hip Recall, Company Reports Third-Quarter Sales Drop, as Hip Replacement Sales Slide 4%

The Smith & Nephew hip recall was announced in June 2012 for a metal liner component used with the company’s metal-on-metal hip implants, Bernstein Liebhard LLP reports.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Bernstein Liebhard LLP | Consumer Injury Lawyers
In light of the recent Smith & Nephew hip recall, as well as the growing concern surrounding metal-on-metal hip implants in general, it’s not surprising that the company saw a decline in sales in the last quarter.

New York, NY (PRWEB) November 03, 2012

Smith & Nephew, a maker of metal-on-metal hip implants and other devices, reported that sales dropped 8% in the third quarter, including a 4% slide for its entire hip replacement franchise.* In June 2012, a Smith & Nephew hip recall was announced for a metal liner component used with the company’s metal-on-metal hip implants after it was found to have an unacceptably high failure rate.**

“In light of the recent Smith & Nephew hip recall, as well as the growing concern surrounding metal-on-metal hip implants in general, it’s not surprising that the company saw a decline in sales in the last quarter,” says Bernstein & Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is currently offering free lawsuit evaluations to victims of the Smith & Nephew hip recall, as well as other metal-on-metal hip implants.

Smith & Nephew Hip Recall
On June 1, 2012, Smith & Nephew announced it was recalling the optional metal liner component of its R3 Acetabular System hip device due to high failure rates associated with the device.* According to the company, annual revision rates in patients with the Smith & Nephew metal liner component were 1.6 percent, which is well above the 1 percent rate Britain’s National Institute for Health and Clinical Evidence deems acceptable. Potential complications from the device include infections, fractures and dislocations, though the company maintains that there is no evidence of the device causing metallosis, or increased metal debris in the body.        

The U.S. Food & Drug Administration (FDA) is currently reviewing the safety of metal-on-metal hip implants amid concerns that metal particles shed by such devices can result in an adverse local tissue reaction that causes damage to bone and/or tissue surrounding the implant and joint. According to the FDA, there are also some case reports in the literature of patients in which high levels of metal ions in the bloodstream may have caused other types of symptoms or illnesses elsewhere in the body, including effects on the heart, nervous system, and thyroid gland.***

The lawyers at Bernstein Liebhard LLP are investigating potential claims on behalf of victims of the Smith & Nephew hip recall, and are also actively filing lawsuits involving the DePuy ASR hip implant and the metal-on-metal Pinnacle hip system. In addition, the firm is investigating cases concerning the Biomet M2a Magnum hip implant, Wright Profemur and Conserve metal hip implants, and the recently recalled Stryker Rejuvenate and ABG II modular-neck hip stems. Individuals who have endured hip implant failures, pain, or revision surgery due to the any of these devices may be entitled to compensation for their medical care, pain and suffering, and other damages. A wealth of information about the Smith & Nephew hip recall, as well as other metal-on-metal hip implant lawsuits, is available at Bernstein Liebhard’s website. For additional information, please call one of our attorneys at 1-877-779-1414 today.

*smith-nephew.com/global/assets/en/documents/q3%202012%20announcement.pdf
**chicagotribune.com/2012-06-01/lifestyle/sns-rt-us-smithnephew-hipbre85010j-20120601_1_metal-on-metal-traditional-implants-smith-nephew
***fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com